CClinicalTrials.gg
Status unknownNCT03634163WECCC-NHBUpdated Aug 16, 2018

Compassionate Communities Neighbourhood Program

An interventional study of Neighbourhood exchange and Quality of Life Assessment in Chronic Disease and Aging, sponsored by McMaster University. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-16.

Sponsored by McMaster University · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate a Compassionate Communities-based intervention aimed at reducing social isolation by mobilizing individuals to act on their health and social needs individually, and in collaboration with fellow members of their community. The intervention program includes facilitated building of neighbourhood networks (member benefits include access to practical help, the opportunity to develop meaningful relationships, and community mobilization), and coaching support to work on individualized goal setting and more detailed navigation support and planning.

Read the detailed description

The Compassionate Communities intervention is catalyzed by professional facilitators who visit communities with high concentrations of elderly and vulnerable residents, and recruit those who are interested in a project to identify their own health and social needs, assets and priorities; to collectively work to support each other in achieving these; and to implement a neighbourhood exchange to more easily match offers of help to people who need help. The mobilization work starts with the facilitator, who is employed by a community or social service organization, but increasingly draws on the energies of the mobilized initial participants as volunteers who conduct further community outreach in their community, attracting and mobilizing other residents, peers, and neighbouring resources in the work. Participants also plan and implement a broad range of activities identified by the residents as their priorities for neighbourhood building. Participants and their caregivers have the option of receiving more in-depth 1:1 coaching support to work on individualized goal setting, more detailed navigation support or advanced care planning following the sessions.

02

Conditions studied

  • Chronic Disease
  • Aging

Browse trials for

Keywords

  • disability
03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 120 across 722 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

McMaster University is the lead sponsor of 720 studies on the registry; 123 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Seniors (65 years of age and older)
  • people with disabilities
  • caregivers of seniors or people with disabilities
  • residing in identified buildings/ neighbourhoods where the WECCC Compassionate Communities Neighbourhood program is being launched
  • able to communicate in English or interpreter can be arranged

Exclusion criteria

Exclusion Criteria:

  • not able to communicate in English and interpreter cannot be arranged
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Immediate

    Quality of Life Assessment plus facilitated implementation of neighbourhood exchange and personal care support

    Behavioral: Neighbourhood exchange · Behavioral: Quality of Life Assessment

  • Active comparator
    Delayed

    Quality of Life Assessment

    Behavioral: Quality of Life Assessment

Interventions

  • BehavioralNeighbourhood exchange

    Facilitated coaching support to identify needs and priorities and link with resources - personal, community, friend and family, or from professional service providers; plan and implement a personalized care pathway through community exchange

  • BehavioralQuality of Life Assessment

    Completion of baseline measures

06

What researchers measure

Primary outcomes

  1. Perception of social disconnectedness

    Social disconnectedness scale; 8-item validated scale (Cornwell and Waite, 2008), higher scores indicate greater social disconnectedness

    Time frame: change from baseline at 7 months

Secondary outcomes

  1. Perception of personal well-being

    Assessed by Personal Well-Being Index (PWI); 8-item scale (Personal well-being index 5th edition, 2013). Higher scores indicate greater well-being

    Time frame: change from baseline at 7 months

  2. Perceived loneliness scale

    Assessed by Perceived loneliness scale; 9-item validated scale (Cornwell and Waite, 2009). Higher scores indicated greater perceived isolation

    Time frame: change from baseline at 7 months

  3. Attainment of personal goals

    Assessed by Goal Attainment Scaling (GAS) instrument, measured on 5-point scale for each goal identified (Hurn et al, 2006), higher score indicates greater goal attainment

    Time frame: Change from baseline at 7 months

  4. Health related quality of life

    Assessed by Euroqol 5 dimension 5 level (5D-5L) scale; 5 levels of response for each of 5 items, score is converted to a single index, standardized to scale of 0 to 1, 1 being perfect health

    Time frame: change from baseline at 7 months

  5. Perceived provisions of social relationships

    Social provisions scale; 10-item validated scale consisting of 5 subscales (Caron, 2013). The SPS 10 measures the perception of social support and consists of 10 items expressed as statements with responses coded on a 4-point scale from strongly disagree (= 1) to strongly agree (= 4). The total SPS-10 score is formed by the summation of raw scores, with high score indicating a higher degree of social provisions (maximum score of 40)

    Time frame: change from baseline at 7 months

  6. Number of emergency department visits

    Number of emergency department visits measured from health administrative data

    Time frame: 7 months

  7. Number of hospital admissions

    Number of hospital admissions measured from health administrative data

    Time frame: 7 months

Other outcomes

  1. Cost-effectiveness

    Cost-effectiveness ratio measured as difference between groups in total health care utilization costs (measured from administrative data) divided by quality adjusted life years gained from the intervention

    Time frame: 7 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03634163
Lead sponsor
McMaster University
Collaborators
Windsor-Essex Compassionate Care Community, University of Windsor, Hospice of Windsor and Essex County, Erie St. Clair Local Health Integration Network (LHIN), Ontario Trillium Foundation
Responsible party
Michelle Howard (Assistant Professor, McMaster University) — Principal investigator
First posted
Aug 16, 2018
Start date
Sep 1, 2018 (estimated)
Primary completion
Mar 31, 2020 (estimated)
Completion
Mar 31, 2021 (estimated)
Last update
Aug 16, 2018

Study contacts

Michelle Howard, PhD
Contact
mhoward@mcmaster.ca
905-525-9140 ext. 28502
Deborah Sattler
Contact
deborah@deborahsattler.ca
416-879-2371
Michelle Howard, PhD
principal investigator · McMaster University
Lisa Dolovich, PharmD
principal investigator · McMaster University
Kathryn Pfaff, PhD
principal investigator · University of Windsor
Merrick Zwarenstein, PhD
principal investigator · Western University
Denise Marshall
principal investigator · McMaster University
Ross Upshur
principal investigator · Sinai Health Systems
Carol Bennett
principal investigator · Ottawa Hospital Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion